The latest closing stock price for Leap Therapeutics as of January 31, 2025 is 0.56.
An investor who bought $1,000 worth of Leap Therapeutics stock at the IPO in 2017 would have $-993 today, roughly -1 times their original investment - a -46.10% compound annual growth rate over 8 years.
The all-time high Leap Therapeutics stock closing price was 100.10 on April 12, 2018.
The Leap Therapeutics 52-week high stock price is 4.79, which is 755.4% above the current share price.
The Leap Therapeutics 52-week low stock price is 0.51, which is 8.9% below the current share price.
The average Leap Therapeutics stock price for the last 52 weeks is 2.68.
An investor who bought $1,000 worth of Leap Therapeutics stock at the IPO in 2017 would have $-993 today, roughly -1 times their original investment - a -46.10% compound annual growth rate over 8 years.
The all-time high Leap Therapeutics stock closing price was 100.10 on April 12, 2018.
The Leap Therapeutics 52-week high stock price is 4.79, which is 755.4% above the current share price.
The Leap Therapeutics 52-week low stock price is 0.51, which is 8.9% below the current share price.
The average Leap Therapeutics stock price for the last 52 weeks is 2.68.